Part 6/9:
The COVID-19 outbreak served as a turning point. Recognizing the urgent need for alternative solutions, Visibly reached out to the FDA, emphasizing how their remote service could help during the crisis by reducing unnecessary in-person contact. Demonstrating flexibility and responsiveness, the FDA granted temporary permission for the company to operate, emphasizing that it was safer to undergo an online exam than to risk exposure in a traditional clinic.
This collaboration marked a significant moment: regulators acknowledged that telehealth in eye care could be both safe and necessary. As a result, hundreds of optometrists and medical doctors across the United States began integrating Visibly’s technology into their practices, helping patients maintain vision health amid restrictions.